NasdaqCM:BSEMPharmaceuticals
BioStem Governance And Hospital Expansion Moves Shape Investor Focus
BioStem Technologies (OTCPK:BSEM) appointed Jodi Ungrodt as a new member of its Board of Directors and Chair of the Audit Committee.
The company completed the acquisition of BioTissue Holdings Inc.'s surgical and wound assets, including a national sales force.
The transaction expands BioStem's commercial reach into hospital settings and broadens its product portfolio.
BioStem Technologies, trading at $4.92, sits at an interesting point in its share price history, with a 25.9% return year to...